Brooks Automation Q4 Results Tops Street; Shares Up 9%

Shares of Brooks Automation, Inc. (BRKS) gained nearly 9% in extended trading session on Tuesday after its fourth-quarter results trumped Wall Street estimates.

Net income for the fourth-quarter was $28.97 million or $0.39 per share, compared to $412.3 million or $5.68 per share last year.

Last year's results included income from discontinued operations of $407.1 million.

Adjusted earnings from continuing operations were $0.47 per share, up from $0.23 per share last year.

Revenues for the fourth quarter rose 24% to $246.2 million from $199.2 million last year.

Analysts polled by Thomson Reuters expected earnings of $0.36 per share on revenues of $234.88 million.

Looking forward to the first quarter, the company expect revenues of $237 million to $251 million and adjusted earnings of $0.37 to $0.47 per share. Analysts currently estimate earnings of $0.32 per share on revenues of $229.96 million.

Further, the company reiterated a dividend of $0.10 per share payable on December 17, 2020 to stockholders of record on December 4 , 2020.

CEO Steve Schwartz said, "The Semiconductor Solutions and Life Sciences businesses each continued their momentum during the quarter, once again achieving operating margin expansion and delivering double-digit growth for the year."

BRKS closed Tuesday's trading at $59.43, down $1.28 or 2.11%, on the Nasdaq. The stock, however, gained $5.07 or 8.53%, in the after-hours trade.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
CVS Health is set to recruit qualified candidates to fill 25,000 clinical and retail jobs during a one-day national career event on Friday, September 24. This will enable CVS to meet the high demand for pharmacists, pharmacy technicians, nurses, and retail store associates to support flu season, COVID-19 vaccinations and testing. Twitter, Inc. (TWTR) announced Monday that it has entered into a binding agreement to settle the consolidated class action lawsuit commenced in 2016 in the United States District Court for the Northern District of California. Under the terms of the proposed settlement, Twitter will pay $809.5 million... Drug major Pfizer has again expanded the earlier two recalls of its anti-smoking Drug Chantix (Varenicline) in the form of tablets, to now include all the lots, for the potential presence of nitrosamine impurity, N-Nitroso- varenicline, at or above the FDA interim acceptable intake limit (ADI), the U.S. Food and Drug Administration or FDA said in a statement.
Follow RTT